Q2 FY2026 Earnings
Financial report interval: 2026.01.30 - 2026.04.30
Overview: Anixa Biosciences(ANIX) the Revenue is 0 (--%), Meet estimate;the EBIT is -2.647 M (+11.85%), Beat estimate;the EPS is -0.07 (+22.22%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B--
0.00B--
0.00B--%
EBITExceed expectations
-0.00B11.85%
-0.00B5.29%
+0.00B6.56%
EPSExceed expectations
-0.0722.22%
-0.0855.56%
+0.015016.66%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf